Amylyx Pharmaceuticals Inc (AMLX) — Free Cash Flow Generation Index
Amylyx Pharmaceuticals Inc (AMLX) has a Free Cash Flow Generation Index of 0.97x as of December 2023. Free cash flow of $13.20 Million represents 1% of operating cash flow ($13.55 Million). See Amylyx Pharmaceuticals Inc (AMLX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Amylyx Pharmaceuticals Inc Free Cash Flow Generation Index (2023–2023)
Historical FCF Generation Index trend for Amylyx Pharmaceuticals Inc across 1 annual periods. Explore Amylyx Pharmaceuticals Inc (AMLX) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Amylyx Pharmaceuticals Inc (2023–2023)
Year-by-year Free Cash Flow Generation Index for Amylyx Pharmaceuticals Inc. For the full company profile including market capitalisation, see AMLX market cap.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.90x | $10.68 Million | $11.92 Million | $1.24 Million | — |